Trial Profile
An open label phase II study of Liprostin for the treatment of Diabetic Neuropathy in patients affected by non-healing ulcers of the foot or ankle
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2016
Price :
$35
*
At a glance
- Drugs Alprostadil (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- 05 Aug 2016 New trial record